The field of bioinformatics, which blends computer science and biology, offers useful resources for comprehending and treating dementia. Through the analysis of enormous volumes of genetic, genomic, and proteomic data, scientists are able to determine prospective therapeutic targets, discover genetic risk factors, and unravel the molecular mechanisms behind the course of disease. Personalized treatment regimens, accelerated drug development, and disease start prediction are all made possible by bioinformatics techniques like machine learning and artificial intelligence. To find early biomarkers and monitor the course of the disease, bioinformatics also helps with the analysis of neuroimaging data.
Track 13-1: Genome-Wide Association Studies
Track 13-2: Transcriptomics
Track 13-3: Proteomics
Track 13-4: Metabolomics
Track 13-5: Machine Learning and Artificial Intelligence
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
